Warrant

Zuma Capital Management Nominates Five Highly Qualified, Independent Director Candidates at Presidio Property Trust

Retrieved on: 
Wednesday, March 13, 2024
Centurion, Resort, Letter, Spinal muscular atrophies, Exercise, Warrant, Trust, Telecommunications, Private law, Employment, TSR, WHEN, International, Compensated emancipation, Common stock, Research, Senior counsel, Security (finance), Retirement, UPON, Fear, Principal, PC, Assistant, Shareholder, Total shareholder return, Common, Capital, Highfields Capital Management, Axos Bank, Partner, WEB

ATLANTA, March 13, 2024 (GLOBE NEWSWIRE) -- Zuma Capital Management, LLC, which owns approximately 7.7% of the outstanding shares of the Series A Common Stock of Presidio Property Trust, Inc. (NASDAQ: SQFT) (“Presidio” or the “Company”), today issued a public letter to the Company’s stockholders announcing its nomination of five highly qualified, independent candidates; Reuben Berman, Stefani Carter, Vito Garfi, Brent Morrison and Elena Piliptchak, for election to the Company’s Board of Directors at the Company’s 2024 Annual Meeting of Stockholders.

Key Points: 
  • Learn more about Zuma Capital Management, LLC’s director candidates by visiting www.SavePresidio.com, where stockholders can download a copy of our letter and sign up for future updates on Zuma Capital Management’s campaign for boardroom change.
  • We have nominated five highly qualified, independent candidates for election to the Board, who have strong experience in commercial real estate, corporate governance and capital allocation.
  • 2 Source: Morningstar (as of March 12, 2024) and Zuma Capital Management Internal Estimates.
  • 3 Source: Morningstar (as of March 12, 2024) and Zuma Capital Management Internal Estimates.

ProStar Holdings Announces Non-Brokered Private Placement

Retrieved on: 
Wednesday, March 13, 2024
Indian stock exchange, TSX Venture Exchange, Offering, Minority, The Company, Warrant, Sale, Regulation, News, MasterCraft, Legislation, Marketing, Person, Security (finance)

GRAND JUNCTION, Colo., March 13, 2024 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar®") a world leader in Precision Mapping Solutions®, is pleased to announce a non-brokered private placement for gross proceeds of up to C$2,500,000 (the "Offering").

Key Points: 
  • GRAND JUNCTION, Colo., March 13, 2024 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar®") a world leader in Precision Mapping Solutions®, is pleased to announce a non-brokered private placement for gross proceeds of up to C$2,500,000 (the "Offering").
  • Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a “Warrant”).
  • The Company will use the proceeds of the Offering for sales, marketing, and working capital requirements.
  • Directors and officers of ProStar and shareholders owning more than 10% of the Common Shares may participate in the Offering for a yet to be determined amount.

AdTheorent Holding Company, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results

Retrieved on: 
Tuesday, March 12, 2024
Growth, Frost, Data science, Warrant, Bank statement, Adjustment, Radar, GAAP, Privacy, Video game

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced fourth quarter and full-year 2023 financial results.

Key Points: 
  • NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced fourth quarter and full-year 2023 financial results.
  • Adjusted Gross Profit* was $39.9 million, an increase of $6.2 million, or 18.2%, compared to fourth quarter 2022.
  • Adjusted EBITDA* was $13.6 million, an increase of $3.5 million, or 34.8%, from $10.1 million in fourth quarter 2022.
  • Adjusted EBITDA* as a percentage of Adjusted Gross Profit* of 34.2% represented an increase from 30.0% in fourth quarter 2022.

Western Exploration Announces Closing of Private Placement

Retrieved on: 
Thursday, March 28, 2024
Mining, Minerals, Natural Resources, Warrant, TSX Venture Exchange, Agnico Eagle, Offering, Security (finance)

Each Unit consists of one variable voting share of the Company (each, a "Share") and one variable voting share purchase warrant of the Company (each whole variable voting share purchase warrant, a "Warrant").

Key Points: 
  • Each Unit consists of one variable voting share of the Company (each, a "Share") and one variable voting share purchase warrant of the Company (each whole variable voting share purchase warrant, a "Warrant").
  • In addition, Canaccord Genuity Corp. served as financial advisor in connection with the Offering and was paid $40,000 for their services.
  • The Company intends to use the net proceeds raised from the Offering for exploration and development expenditures at the Aura Project in Nevada, and for general corporate purposes.
  • The following insiders of the Company have subscribed for Units under the Offering:

Organigram Announces Launch of Overnight Marketed Public Offering

Retrieved on: 
Tuesday, March 26, 2024
Cannabis, Food, Beverage, Natural Resources, Retail, Specialty, Offering, Form, Telephone, EDGAR, Warrant, Sale, News, Toronto Stock Exchange, United, Suite, TSX, Investment, Unit, OGI, Register, Security (finance)

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”).

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”).
  • The Offering will be made in the United States through the lead underwriter's U.S. affiliate, ATB Capital Markets USA Inc.
  • There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
  • The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering.

NYSE to Commence Delisting Proceedings with Respect to the Warrants of Custom Truck One Source, Inc. (CTOS.WS)

Retrieved on: 
Friday, March 15, 2024
Professional Services, Finance, Exchange, Committee, Warrant, Security (finance), New York Stock Exchange

The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the redeemable warrants, exercisable for common stock of Custom Truck One Source, Inc. (the “Company”) (the “Warrants”) — ticker symbol CTOS.WS — from the NYSE.

Key Points: 
  • The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the redeemable warrants, exercisable for common stock of Custom Truck One Source, Inc. (the “Company”) (the “Warrants”) — ticker symbol CTOS.WS — from the NYSE.
  • Trading in the Company’s common stock — ticker symbol CTOS — will continue on the NYSE.
  • NYSE Regulation has determined that the Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Graphite One Announces Closing of Early Warrant Exercise Incentive Program

Retrieved on: 
Tuesday, April 2, 2024
Exercise, Warrant, Graphite, Taiga, Policy, Security (finance)

VANCOUVER, BC, April 2, 2024 /PRNewswire/ - Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) ("Graphite One" or the "Company") is pleased to announce that further to its press releases dated February 13, 2024 and February 20, 2024, the Company has closed its early warrant exercise incentive program (the "Warrant Incentive Program") receiving aggregate gross proceeds of Cdn$5,130,873 from the exercise of 5,130,873 outstanding common share purchase warrants (the "Warrants"), which included Taiga's exercise of 2,258,957 Warrants.

Key Points: 
  • VANCOUVER, BC, April 2, 2024 /PRNewswire/ - Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) ("Graphite One" or the "Company") is pleased to announce that further to its press releases dated February 13, 2024 and February 20, 2024, the Company has closed its early warrant exercise incentive program (the "Warrant Incentive Program") receiving aggregate gross proceeds of Cdn$5,130,873 from the exercise of 5,130,873 outstanding common share purchase warrants (the "Warrants"), which included Taiga's exercise of 2,258,957 Warrants.
  • The exercise price on the remaining 6,824,804 Warrants that were not exercised during the Warrant Exercise Period revert back to the original terms as they existed prior to the Warrant Incentive Program.
  • The Warrant Incentive Program was designed to encourage the exercise of outstanding Warrants issued as part of the Company's private placements which closed August 28, 2022, November 21, 2022 and September 17, 2023.
  • In connection with the exercise of the Warrants under the Warrant Incentive Program, the Company issued an aggregate of 5,130,873 common share purchase warrants (the "Sweetener Warrants") to such warrant holders who exercised under the Warrant Incentive Program.

Notice of Annual General Meeting 2024 in Enzymatica AB (publ)

Retrieved on: 
Wednesday, March 27, 2024
Transfer, Remuneration, Consultant, Employment, Annual report, Disability, Motivation, Exercise, Social Security, Warrant, Economic development, Policy, Ideon Science Park, Retirement, Companies Act, Security (finance)

LUND, Sweden , March 27, 2024 /PRNewswire/ -- The annual general meeting of Enzymatica AB (publ), reg. no. 556719-9244, will be held on 7 May 2024 at 14:30 CET, Elite Hotel Ideon, Scheelevägen 27 in Lund.

Key Points: 
  • Transfer of warrants may not take place after the annual general meeting 2025.
  • 1.1  These guidelines for remuneration include salaries and other remuneration for the senior executives in Enzymatica AB (publ) ("Enzymatica" or the "company").
  • The proposal for guidelines presented at the 2024 annual general meeting is substantially consistent with the previous guidelines and has not resulted in any significant changes.
  • If such deviation occurs, the board of directors shall report the reasons for the deviation at the closest following annual general meeting.

CSE Bulletin: New Listing - Planet 13 Holdings Inc. 7MAR2029 Warrants (PLTH.WT)

Retrieved on: 
Thursday, March 7, 2024
Holding, Warrant, Department store

Toronto, Ontario--(Newsfile Corp. - Le 7 mars/March 2024) - Planet 13 Holdings Inc. 7MAR2029 Warrants have been approved for listing.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 7 mars/March 2024) - Planet 13 Holdings Inc. 7MAR2029 Warrants have been approved for listing.
  • Each Warrant shall entitle the holder thereof to purchase one common share of the company upon payment of an exercise price of US$0.77, subject to the terms of the warrant agency agreement governing the warrants (the “Warrant Agreement”).
  • Les bons de souscription Planet 13 Holdings Inc. 7MAR2029 ont été approuvés pour la cotation.
  • Voir l'accord de bon de souscription pour tous les détails et conditions.

ME Therapeutics Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Wednesday, March 6, 2024
News, Sale, Warrant, METX, Therapy, Unit, Acceleration, Cancer, Offering, Research, Security (finance)

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.
  • Each Unit is comprised of one common share of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant").
  • All securities issued in connection with the Offering are subject to a statutory hold period expiring four months and one day after the date of the Closing.
  • No finder's fees were paid in connection with the Offering.